Dr Saraswati

Saraswati Bio is a pre-clinical stage biotechnology company focused on developing novel epigenetic therapies for the treatment of cancer, particularly breast cancer. Founded by Dr. Saraswati Sukumar, a renowned oncologist at Johns Hopkins University, the company leverages proprietary technology to re-express tumor suppressor genes that have been silenced by epigenetic mechanisms. Their lead programs focus on targeting specific homeobox genes and DNA methyltransferases to restore normal cellular function and inhibit tumor growth. Saraswati Bio aims to provide more effective and less toxic treatment options for patients with aggressive or treatment-resistant forms of cancer.